Please rate:

Ventrus Biosciences (VTUS) Acquisition of Title to

  • Uploaded by Karmastock on Nov 21, 2011
  • Hits: 146

Ventrus BioSciences Incorporated - symbol VTUS - reported that it has completed its acquisition of all rights and title to VEN 309 - iferanserin ointment for the treatment of symptomatic hemorrhoids - from the licensor, Sam Amer & Company.



Show Description Hide Description